Skip to content

CONEXUS PHARMA

Absorbed by REGON on 30-01-2018 KBO/BCE: BE 0538.611.801 subsidiary of REGON

Parent

Belgium · 100% of the shares · equity €2.5m · profit €52,477 (2025)

Earlier ties

via , at CONEXUS PHARMA, last mentioned in 2014 · Director · deed of 29-03-2023
founded in 2007
76 FTE (2025)
via , at CONEXUS PHARMA, last mentioned in 2014 · Director (not named in the articles) · deed of 23-08-2023
founded in 2023
total assets €18,255 (2025)
via , at CONEXUS PHARMA, last mentioned in 2014 · Director · deed of 10-02-2016
Absorbed
via , at CONEXUS PHARMA, last mentioned in 2014 · Managing director · deed of 29-04-2016
Absorbed

Acquisitions and mergers

1 transaction
Taken over by:REGON
BE 0890.752.879operation treated as a merger by absorption · Gazette deed of 30-01-2018 (3 deeds)

Connections & network

Depth
Shared corporate director Shared corporate director Shared corporate director Shared corporate director CONEXUS PHARMA CONEXUSPHARMA0538.611.801
Shared directors
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.